FLSM
ALLK

Frazier Life Sciences Management’s Allakos ALLK Stock Holding History

Frazier Life Sciences Management’s Portfolio ALLK Stock Details ALLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,112,684
Closed -$4.95M – 49
2023
Q1 		$4.95M Sell
1,112,684
-3,679,316
-77% -$23.5M 0.36% 42
2022
Q4 		$40.3M Hold
4,792,000
– – 2.51% 13
2022
Q3 		$29.3M Buy
+4,792,000
New +$20.1M 2.26% 13

Other funds holding ALLK

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Frazier Life Sciences Management's ALLK Position: Q2 2023 in Review

Frazier Life Sciences Management sold out of Allakos (ALLK) in Q2 2023, closing a stake of 1,112,684 shares — an estimated $4.95M sold.

Frazier Life Sciences Management first reported a position in ALLK in Q3 2022 and held it in 3 quarters. The position peaked at $40.3M in Q4 2022. 131 funds tracked by Wall St. Rank hold ALLK as of Q2 2023.

  • Frazier Life Sciences Management reported no remaining Allakos position as of Q2 2023 after selling out during the quarter.
  • Frazier Life Sciences Management sold 1,112,684 Allakos shares in Q2 2023, an estimated $4.95M.
  • Frazier Life Sciences Management first reported a position in Allakos in Q3 2022 and held it in 3 quarters.
  • Frazier Life Sciences Management's Allakos position peaked at $40.3M in Q4 2022.
  • 131 funds tracked by Wall St. Rank held Allakos as of Q2 2023.

Based on Frazier Life Sciences Management's 13F filing for Q2 2023, filed 14 Aug 2023.